Fresenius Medical Care Launches National Retail Pharmacy for Dialysis
Fresenius Medical Care Rx Offers Patients Convenience and 24-7 Access
to Specially Trained Pharmacists
NASHVILLE, Tenn.--(BUSINESS WIRE)--Fresenius Medical Care North America, operator of the nation’s leading
network of dialysis facilities, today announced the launch of its new
national retail pharmacy, Fresenius Medical Care Rx. The pharmacy can
provide dialysis patients with all of their prescriptions,
over-the-counter medications and diabetic testing supplies directly
through the mail at no additional cost.
Fresenius Medical Care Rx gives patients the convenience of ordering
medications and supplies from a single source and provides access to a
pharmacist with specialized training and expertise in the pharmaceutical
requirements of patients living with kidney disease, 24 hours a day,
seven days a week.
Other benefits of Fresenius Medical Care Rx include:
quality of care by making pharmacy services easy and focused on the
specific needs of patients and their physicians," said Patrick Guiney,
senior vice president, Fresenius Medical Care Rx. "People living with
kidney disease often have several doctors and take multiple medications.
Our service can give patients the confidence that all of their pharmacy
needs are met through one source, from prescription fulfillment and
refills, with attention to possible drug interactions and coordination
Fresenius Medical Care Rx is headquartered in Nashville, Tenn. in a
12,000 square-foot facility that maintains a call center and
professional pharmacy staff. Please call 1-800-947-3131 to learn
more about Fresenius Medical Care Rx pharmacy services.
The pharmacy service is a new program that aligns with Fresenius Medical
Care’s UltraCare® mission to deliver excellent care to
patients through innovative programs, the latest technology, continuous
quality improvement and a focus on superior customer service.
Dialysis is a life-sustaining process that cleans waste products from
the blood, removes extra fluids, and controls the body’s chemistry when
a person’s kidneys fail. Dialysis patients typically require treatment
on an ongoing basis unless they receive a kidney transplant.
About Fresenius Medical Care North America
Fresenius Medical Care North America is a subsidiary of Fresenius
Medical Care AG & Co. KGaA, the world's largest integrated provider of
products and services for individuals undergoing dialysis because of
chronic kidney failure, a condition that affects more than 1,600,000
individuals worldwide. Through its network of 2,388 dialysis clinics in
North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius
Medical Care provides dialysis treatment to approximately 184,080
patients around the globe. Fresenius Medical Care is also the world's
leading provider of dialysis products such as hemodialysis machines,
dialyzers and related disposable products. Fresenius Medical Care is
listed on the Frankfurt Stock Exchange (FME, FME3) and the New York
Stock Exchange (FMS, FMS-p).
For more information about Fresenius Medical Care's U.S. network of more
than 1,700 dialysis facilities, visit the Company's website at www.ultracare-dialysis.com
(in English and Spanish). For more information about Fresenius Medical
Care, visit the Company’s websites: www.fmcna.com